Trends in the incidence of thyroid cancer among US persons from 2000 to 2019.

IF 2.1 4区医学 Q3 ONCOLOGY

European Journal of Cancer Prevention Pub Date : 2024-01-01 Epub Date: 2023-07-12 DOI:10.1097/CEJ.0000000000000827

Juebo Yu

{"title":"Trends in the incidence of thyroid cancer among US persons from 2000 to 2019.","authors":"Juebo Yu","doi":"10.1097/CEJ.0000000000000827","DOIUrl":null,"url":null,"abstract":"Background: The incidence of thyroid cancer is increasing by 3% annually; however, the analysis was restricted to the period from 1973 to 2013, which could be changed in incidence trends over time. This study is to analyze trends in thyroid cancer incidence based on demographic and tumor characteristics at diagnosis using recent database.Methods: We used the Surveillance, Epidemiology, and End Results database to assess thyroid cancer incidence rates and trends from 2000 to 2019. We compared incidence rates for thyroid cancer among US persons by age, sex, race/ethnicity, and economic status (SES) and identified trends using Joinpoint software.Results: During 2000 to 2019, the overall thyroid cancer incidence was 13.22/100 000. This study found a decreasing trend in the incidence of thyroid cancer from 2014 to 2019 in the US with significant differences among age, sex, race and ethnicity, geographic region, SES, and tumor subtype. Specifically, the largest reduction in annual percentage changes in persons with all thyroid cancer and papillary thyroid cancer (PTC) in 55-69 years, female, Black, highest SES, urban region, and non-Hispanic ethnicity groups were identified.Conclusion: These results suggested that there is still a high epidemic of thyroid cancer in the US, whereas the rapidly increasing incidence rates of thyroid cancer have reversed since 2015, especially the incidence rates of PTC.","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"5-10"},"PeriodicalIF":2.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10702690/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer Prevention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CEJ.0000000000000827","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The incidence of thyroid cancer is increasing by 3% annually; however, the analysis was restricted to the period from 1973 to 2013, which could be changed in incidence trends over time. This study is to analyze trends in thyroid cancer incidence based on demographic and tumor characteristics at diagnosis using recent database.

Methods: We used the Surveillance, Epidemiology, and End Results database to assess thyroid cancer incidence rates and trends from 2000 to 2019. We compared incidence rates for thyroid cancer among US persons by age, sex, race/ethnicity, and economic status (SES) and identified trends using Joinpoint software.

Results: During 2000 to 2019, the overall thyroid cancer incidence was 13.22/100 000. This study found a decreasing trend in the incidence of thyroid cancer from 2014 to 2019 in the US with significant differences among age, sex, race and ethnicity, geographic region, SES, and tumor subtype. Specifically, the largest reduction in annual percentage changes in persons with all thyroid cancer and papillary thyroid cancer (PTC) in 55-69 years, female, Black, highest SES, urban region, and non-Hispanic ethnicity groups were identified.

Conclusion: These results suggested that there is still a high epidemic of thyroid cancer in the US, whereas the rapidly increasing incidence rates of thyroid cancer have reversed since 2015, especially the incidence rates of PTC.

查看原文本刊更多论文

2000 年至 2019 年美国甲状腺癌发病率趋势。

背景：甲状腺癌的发病率正以每年3%的速度递增；然而，分析仅限于1973年至2013年这一时期，随着时间的推移，发病趋势可能会发生变化。本研究旨在利用最新数据库，根据诊断时的人口统计学特征和肿瘤特征，分析甲状腺癌的发病趋势：我们利用监测、流行病学和最终结果数据库评估了2000年至2019年的甲状腺癌发病率和发病趋势。我们按年龄、性别、种族/民族和经济状况（SES）比较了美国人的甲状腺癌发病率，并使用Joinpoint软件确定了发病趋势：2000年至2019年期间，甲状腺癌的总发病率为13.22/10万。本研究发现，从 2014 年到 2019 年，美国甲状腺癌发病率呈下降趋势，不同年龄、性别、种族和民族、地理区域、经济地位和肿瘤亚型之间存在显著差异。具体而言，55-69 岁、女性、黑人、社会经济地位最高、城市地区和非西班牙裔群体中所有甲状腺癌和甲状腺乳头状癌（PTC）患者的年百分比变化降幅最大：这些结果表明，美国的甲状腺癌流行率仍然很高，而自2015年以来，甲状腺癌发病率快速上升的趋势已经逆转，尤其是PTC的发病率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Cancer Prevention 医学-肿瘤学

CiteScore

4.10

自引率

4.20%

发文量

审稿时长

1 months

期刊介绍： European Journal of Cancer Prevention aims to promote an increased awareness of all aspects of cancer prevention and to stimulate new ideas and innovations. The Journal has a wide-ranging scope, covering such aspects as descriptive and metabolic epidemiology, histopathology, genetics, biochemistry, molecular biology, microbiology, clinical medicine, intervention trials and public education, basic laboratory studies and special group studies. Although affiliated to a European organization, the journal addresses issues of international importance.